3D Medicines Funding: $241M Raised, Investors & Rounds
3D Medicines is based in Qingdao, Shandong, China. It has raised $241M in total funding. Backed by Efung Capital, China Capital Management, Adrian Cheng.
3D Medicines funding overview
3D Medicines is based in Qingdao, Shandong, China. 3D Medicines has raised $241M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for 3D Medicines runs through 2020; nothing later has been disclosed. Investors on record include Efung Capital, China Capital Management, Adrian Cheng, Ruiyi Investment, Tigermed, Shanghai Ruixia and 3 others. 9 distinct backers are named across the disclosed rounds.
3D Medicines at a glance
Total raised
$241M
Latest round date
October 2020
Headquarters
Qingdao, Shandong, China
Notable investors
Efung Capital, China Capital Management, Adrian Cheng, Ruiyi Investment, Tigermed, Shanghai Ruixia, Header Capital, China Reform Holdings
Frequently asked about 3D Medicines funding
How much has 3D Medicines raised?
3D Medicines has raised $241M in total disclosed funding across the rounds on record.
Who has invested in 3D Medicines?
Efung Capital, China Capital Management, Adrian Cheng, Ruiyi Investment, Tigermed, Shanghai Ruixia are named among the investors backing 3D Medicines.
What was the latest 3D Medicines funding round?
No round stage has been disclosed for 3D Medicines.
Where is 3D Medicines based?
3D Medicines is based in Qingdao, Shandong, China.
When did 3D Medicines last raise?
The last disclosed 3D Medicines round closed in October 2020.
3D Medicines totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Qingdao below to benchmark round size and investor mix.
